Skip to main content
. 2023 Jun 15;15(6):1745. doi: 10.3390/pharmaceutics15061745

Figure 5.

Figure 5

(a) (i) TEM image of PAA-coated Ho2O3 NPs (labeled with dotted circles) and (ii) in vivo T2 MR images of mouse liver (labeled as “L”) and kidneys (labeled as “K”), before (labeled as “Pre”) and 15 or 16 min after intravenous injection of PAA-coated Ho2O3 NPs into mice tails at 3.0 and 9.4 T [96]. (b) (i) TEM image (labeled with dotted circles) and (ii) in vivo T2 MR images of mouse liver and kidneys at 3 T, before (labeled as “pre”) and 4 h after intravenous injection of PEGD250-coated Ho2O3 NPs [98].